The symmetry is striking: CSG’s order backlog stands at €17 billion, yet the stock ended last week at €14.28, a mere 4.62% above its 52-week trough of €13.65. Over the past month the shares have shed roughly a quarter of their value, and with no corporate news scheduled until early August, the next move depends entirely on forces outside the group’s control.
Technicals Offer Little Comfort
The chart tells a sobering story. CSG trades 19% below its 50-day moving average of €17.56 and a long way from the 100-day line at €23.25. The relative strength index sits at 35.3 — not yet deep into oversold territory, but low enough to signal that momentum remains firmly bearish. Adding to the fragility, the 30-day annualised volatility clocks in at 55.75%. In such a nervous tape, even modest headlines from the European defence sector can trigger outsized swings.
First-quarter results released earlier this year showed revenue climbing nearly 14% to €1.54 billion, fuelling a record order pile. Yet that operational strength has done nothing to arrest the slide. Investors are asking why a company with such a full pipeline and direct exposure to Brussels’ rearmament push is trading as if it were firing blanks.
Political Tailwinds vs. Market Skepticism
The European Union’s latest summit lent fresh rhetorical support to defence spending. By 2030, the bloc wants a step-change in capabilities — drone defence, air defence, ammunition — all areas where CSG has a strong footprint. The trouble is that the market has grown impatient with declarations. “Political intent” no longer moves the needle; the market wants signed contracts.
That impatience is most visible around the Slovak ZVS munitions framework agreement. The headline figure of €58 billion over seven years is often cited, but CSG itself clarified in a May 5 statement that this represents a potential ceiling, not a guaranteed order book. Individual countries, including Croatia which signed a defence-cooperation memorandum of intent with Slovakia in June, call off deliveries as needed. No Croatian order under that framework has been announced.
Should investors sell immediately? Or is it worth buying CSG?
Meanwhile, the group’s AviaNera Technologies unit struck a strategic partnership with Ukrainian Armor at Eurosatory 2026, focusing on propulsion systems for Ukrainian missile and drone platforms. The agreement leaves the door open for future joint ventures, but no specific contract value was disclosed.
The Next Near-Term Test: Flash PMIs
With the corporate calendar empty until the quiet period begins on July 8, macro data take centre stage. On June 23, S&P Global publishes flash purchasing managers’ indices for France, Germany and the euro area. For a European defence and aerospace name, these releases matter: they shape expectations for industrial activity and, more importantly, for the broader risk appetite that determines whether beaten-down stocks can find a bid.
Adding to the macro weight, the European Central Bank raised all three key rates by 25 basis points on June 11, lifting the deposit rate to 2.25%. The ECB’s data-dependent stance puts extra emphasis on the incoming PMI readings.
A Narrow Safety Margin
The immediate risk is clear. If CSG slips below €13.65, a fresh wave of selling could push the shares into uncharted territory. Hold that level, and the current price may offer a floor for a technical bounce — one that would be helped, not hindered, by the supportive geopolitical backdrop.
The company’s next scheduled milestone is the half-year report on August 7. Until then, investors are left to watch the charts and the PMI ticker, hoping that narrative and reality start to converge.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from June 21 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 21.
CSG: Buy or sell? Read more here...









